Derek Hicks
EVP, Chief Business Officer, Intellia Therapeutics.
Companies
- Intellia TherapeuticsEVP, Chief Business Officer Dec 29, 2021 to Jan 7, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Intellia Therapeutics NTLA59,878 shares2$687.4K at $11.48Jan 3, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 3, 2025Sold 6,502 shares at $12.18 of Intellia Therapeutics2
- Mar 1, 2024Granted 29,393 shares of Intellia Therapeutics3
- Jan 3, 2024Sold 3,877 shares at $29.46 of Intellia Therapeutics4
- Mar 1, 2023Granted 23,558 shares of Intellia Therapeutics5
- Jan 4, 2023Sold 1,812 shares at $37.21 of Intellia Therapeutics6
- Jan 3, 2022Granted 19,118 shares of Intellia Therapeutics7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 5, 2024
- 4SEC EDGARForm 4 filed Jan 5, 2024
- 5SEC EDGARForm 4 filed Mar 3, 2023
- 6SEC EDGARForm 4 filed Jan 6, 2023
- 7SEC EDGARForm 4 filed Jan 5, 2022